CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 73 filers reported holding CHEMOCENTRYX INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $737,000 | +128.9% | 54,178 | 0.0% | 0.02% | +166.7% |
| Q4 2017 | $322,000 | -19.9% | 54,178 | 0.0% | 0.01% | -33.3% |
| Q3 2017 | $402,000 | -20.7% | 54,178 | 0.0% | 0.01% | -25.0% |
| Q2 2017 | $507,000 | +28.7% | 54,178 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $394,000 | -29.3% | 54,178 | -28.0% | 0.01% | -28.6% |
| Q4 2016 | $557,000 | +22.7% | 75,206 | 0.0% | 0.01% | +16.7% |
| Q3 2016 | $454,000 | +34.3% | 75,206 | 0.0% | 0.01% | +33.3% |
| Q2 2016 | $338,000 | +150.4% | 75,206 | +38.8% | 0.01% | +125.0% |
| Q1 2016 | $135,000 | -69.2% | 54,178 | 0.0% | 0.00% | -66.7% |
| Q4 2015 | $439,000 | +33.8% | 54,178 | 0.0% | 0.01% | +20.0% |
| Q3 2015 | $328,000 | -44.6% | 54,178 | -24.7% | 0.01% | -78.7% |
| Q2 2015 | $592,000 | +9.0% | 71,960 | 0.0% | 0.05% | +235.7% |
| Q1 2015 | $543,000 | +10.6% | 71,960 | 0.0% | 0.01% | +7.7% |
| Q4 2014 | $491,000 | +51.5% | 71,960 | 0.0% | 0.01% | +62.5% |
| Q3 2014 | $324,000 | -23.0% | 71,960 | 0.0% | 0.01% | -27.3% |
| Q2 2014 | $421,000 | -11.7% | 71,960 | 0.0% | 0.01% | -15.4% |
| Q1 2014 | $477,000 | +61.7% | 71,960 | +41.3% | 0.01% | +44.4% |
| Q4 2013 | $295,000 | – | 50,932 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |